Company / Interest Expense per Share
GeneDx Holdings Corp. Interest Expense per Share History
FY2019-FY2022 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense per Share
$625.02
FY2022
5-year range
$625.02 / $22862.90
FY2019-FY2022
Trend
-97.3%
vs FY2021
Sector context
#1 of 40
Health Care
What the data says
Among 40 Health Care companies, GeneDx Holdings Corp. is in the bottom 2% for interest expense per share. Increased from $482.17 to $625.02 over the past 2 years.
Based on SEC 10-K filings.
625.02 in FY2022 with a 3-year CAGR of -53.7%. Ranks 1st among 40 companies in Health Care.
Increased from $482.17 to $625.02 over the past 2 years.
Health Care sector context is included.
Interest Expense per Share over time
Growth rates
- 3-Year CAGR
- -53.7%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 2% in Health CareTop 98% of 40This company $625.02 Sector average $1.56
▼
+39871.4% above sector average
Key checks
Key Insights
- In FY2022, interest expense per share decreased 97.3% year-over-year.
- Ranks #1 out of 40 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score -0.67 (distress zone, below 1.8 threshold)
- Negative profit margin: -17.1%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest Expense per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | $625.02 | -97.3% |
| FY2021 | $22862.90 | +4641.7% |
| FY2020 | $482.17 | -92.4% |
| FY2019 | $6314.52 | - |
As of FY2022 · SEC 10-K · Updated Feb 28, 2026